quindoxin has been researched along with Tuberculosis, Drug-Resistant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moreno-Viguri, E; Pérez-Silanes, S; Santivañez-Veliz, M; Torres, E | 1 |
| Aldana, I; Cho, SH; Franzblau, SG; Goldman, RC; Lenaerts, AJ; Maddry, JA; Monge, A; Pérez-Silanes, S; Solano, B; Vicente, E; Villar, R | 1 |
2 other study(ies) available for quindoxin and Tuberculosis, Drug-Resistant
| Article | Year |
|---|---|
Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis.
Topics: Animals; Antitubercular Agents; Cell Line; Cyclic N-Oxides; Drug Resistance, Multiple, Bacterial; Latent Tuberculosis; Mice; Mycobacterium tuberculosis; Quinoxalines; Tuberculosis, Multidrug-Resistant | 2016 |
In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide.
Topics: Administration, Oral; Animals; Antitubercular Agents; Biotransformation; Drug Resistance, Multiple, Bacterial; Female; Mice; Microbial Sensitivity Tests; Microbial Viability; Molecular Structure; Mycobacterium tuberculosis; Quinoxalines; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2008 |